Florence Vallelian
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
von Kempis J, Duetsch S, Reuschling N, Villiger R, Villiger P, Vallelian F, Schaer D, Mueller R. Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland. Swiss Med Wkly 2019; 149:w20022.
Mar 10, 2019Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
Mar 10, 2019Swiss Med Wkly 2019; 149:w20022
von Kempis Johannes, Duetsch Sabine, Reuschling Nicola, Villiger Rahel, Villiger Peter M, Vallelian Florence, Schaer Dominik J, Mueller Ruediger B
51-year-old man with with acute coronary syndrome and bipulmonary infiltrates
von Kempis J, Deutsche S, Reschling N, Villiger R, Villiger P, Vallelian F, Scher D, Mueller R. 51-year-old man with with acute coronary syndrome and bipulmonary infiltrates. Swiss Medical Weekly 2019; 2019;149:w20022
Mar 10, 201951-year-old man with with acute coronary syndrome and bipulmonary infiltrates
Mar 10, 2019Swiss Medical Weekly 2019; 2019;149:w20022
von Kempis Johannes, Deutsche Sabine, Reschling Nicola, Villiger Rahel, Villiger Peter M, Vallelian Florence, Scher Dominik, Mueller Ruediger B
[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
Ritter A, Burow A, Vallelian F, Schaer D. [Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects]. Praxis (Bern 1994) 2014; 103:987-98; quiz 996.
Aug 20, 2014[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
Aug 20, 2014Praxis (Bern 1994) 2014; 103:987-98; quiz 996
Ritter Alexander, Burow Annika, Vallelian Florence, Schaer Dominik J